Although BRAF V600E is a dominant driver of mutations that are widely associated with melanoma aggressiveness [19], a small portion of resistant melanomas take advantage of the activation of the compensatory PI3K–Akt signalling cascade sustained by different genetic alterations. Here, BRAF is linked to melanoma.